ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1814

Silica and Other Exposures from Jobs and Hobbies Are Associated with Myositis Phenotype in a National Myositis Registry

Christine Parks1, Jesse Wilkerson2, Payam Noroozi Farhad3, Nastaran Bayat4, Adam Schiffenbauer5, Hermine Brunner6, Robert Goldberg7, Frederick Miller8 and Lisa Rider5, 1Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 2NIEHS/NIH, Durham, NC, 3Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, 4Social Scientific Systems, DLH Holdings Corp, Silver Spring, MD, 5NIEHS, NIH, Bethesda, MD, 6Cincinnati Children's Hospital Medical Center, Division of Rheumatology, Cincinnati, OH, 7Myositis Foundation, Alexandria, VA, 8NIH, NIEHS, Chapel Hill, NC

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, dermatomyositis, Environmental factors, Epidemiology, Occupation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1796–1826) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Growing evidence suggests that environmental factors may contribute to disease phenotype among patients diagnosed with the idiopathic inflammatory myopathies (IIM), dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM), as well as the anti-synthetase syndrome (SYN)-associated lung disease (LD). Occupational exposures, includingrespirable silica dust, have been associated with some systemic autoimmune diseases and lung disease, but associations with IIM phenotype are not well understood.

Methods: We analyzed data from 1390 adult IIM patients (ages 18-65) in a national patient registry (including 658 dermatomyositis [DM], 451 polymyositis [PM], and 309 inclusion body myositis [IBM]) diagnosed through 2011. Other phenotype data included self-reported lung involvement, fever, arthritis, and reported diagnosis of other autoimmune rheumatic diseases (ARD). A self-administered questionnaire asked about specific jobs, hobbies, longest held job (year started/stopped), and exposures prior to diagnosis. Responses were evaluated in a blinded expert review and rules-based assessment to assign exposure intensity with certainty ratings forrespirable silica dust (derived from quartz in rock, sand, or soil), solvents, and heavy metals prior to diagnosis. We examined exposure associations with (1) DM or PM vs. IBM, (2) LD+ fever or arthritis (SYN phenotype; N=218; 16%) vs. no LD (N=1028) and (3) comparing those with overlapping ARD (N=166; 12%) vs. no ARD (N=1224). We calculated odds ratios (OR) and 95% confidence intervals (CI) in logistic regression models adjusted for age and gender.

Results: High silica exposure was associated with increased odds of DM compared to IBM (OR 2.02; 95%CI 1.18, 3.46; p-trend=0.004 vs. unexposed), and the SYN phenotype (1.71; 1.07, 2.74; p-trend=0.005), which was also associated with high or moderate exposure to heavy metals (1.49; 1.00, 2.14; p-trend=0.026). High silica exposure was also associated with the ARD-overlap phenotype (2.07; 1.19, 3.61; p-trend=0.02) and the OR was elevated for high or moderate heavy metal exposure (1.59; 0.99, 2.55, p-trend=0.051). Associations limited to high certainty exposures were stronger for silica exposure and the DM, SYN, and ARD phenotypes, and for heavy metals and the SYN phenotype, and results were similar when limited to female participants.Solvent exposure was not associated with DM or PM (vs. IBM), or the SYN or ARD-overlap phenotypes.

Conclusion: These findings suggest that intense occupational exposure to respirable silica dust and exposure to heavy metals may contribute to distinctive disease phenotypes in adult IIM patients, including lung involvement, one of the more severe manifestations of IIM, and overlap with other ARD. Larger clinical studies, including rigorous exposure assessment, are warranted to identify high risk patients and investigate potential etiologies.

Supporting image 1

Supporting image 2

Table 2. Occupational Exposures, the SYN phenotype, and ARD overlap


Disclosures: C. Parks: None; J. Wilkerson: None; P. Noroozi Farhad: None; N. Bayat: None; A. Schiffenbauer: Hope, 5; H. Brunner: AbbVie, 2, AstraZeneca-Medimmune, 2, Biogen, 2, Boehringer-Ingelheim, 2, Bristol-Myers Squibb (BMS), 2, 5, Celgene, 2, Eli Lilly, 2, 5, EMD Serono, 2, F-Hoffman La Roche, 2, 5, GlaxoSmithKlein (GSK), 2, 5, 6, Horizon, 2, 2, Janssen, 5, Merck, 2, Novartis, 2, 5, 6, Pfizer, 2, 5, 6; R. Goldberg: None; F. Miller: Argenx, 1, Cabaletta, 1, Pfizer, 2, 2; L. Rider: AstraZeneca, 5, Bristol-Myers Squibb(BMS), 5, Hope Pharmaceuticals, 5.

To cite this abstract in AMA style:

Parks C, Wilkerson J, Noroozi Farhad P, Bayat N, Schiffenbauer A, Brunner H, Goldberg R, Miller F, Rider L. Silica and Other Exposures from Jobs and Hobbies Are Associated with Myositis Phenotype in a National Myositis Registry [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/silica-and-other-exposures-from-jobs-and-hobbies-are-associated-with-myositis-phenotype-in-a-national-myositis-registry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/silica-and-other-exposures-from-jobs-and-hobbies-are-associated-with-myositis-phenotype-in-a-national-myositis-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology